LeukopeniaDrug EvaluationThrombocytopeniaAntineoplastic Combined Chemotherapy ProtocolsDrug Administration ScheduleLeukocyte CountCisplatinFluorouracilInfusions, IntravenousPaclitaxelHematologic DiseasesTreatment OutcomeNeutropeniaDoxorubicinAntineoplastic Agents, PhytogenicBlood Cell CountCyclophosphamideDose-Response Relationship, DrugLung NeoplasmsAntineoplastic AgentsCombined Modality TherapyVinblastineGastric FistulaCellophaneTime FactorsEtoposideCarboplatinNauseaLeukocytesTaxoidsAnemiaBone MarrowBone Marrow DiseasesSurvival AnalysisPhlebovirusGastrointestinal ContentsGranulocyte Colony-Stimulating FactorMenogarilEhrlichiaDeoxycytidineCamptothecinAminopterinSurvival RateEhrlichiosisLevamisoleAntimetabolites, AntineoplasticMycophenolic AcidVomitingLeucovorinNogalamycinNeoplasmsDisease-Free SurvivalPlatelet CountAlopeciaAzathioprineCarcinoma, Small CellCarcinoma, Non-Small-Cell LungStomatitisErythrocyte CountRemission InductionBunyaviridae InfectionsNeoplasm MetastasisRickettsiaceae InfectionsFeverMaximum Tolerated DoseAntineoplastic Agents, AlkylatingGranulocytesIfosfamidePneumonia, StaphylococcalImmunosuppressive AgentsMethotrexateAgranulocytosisRecombinant ProteinsBase CompositionAdministration, OralPancytopeniaRandom AllocationMechlorethamineNeoplasm Recurrence, LocalSalvage TherapyInfusions, ParenteralNeoplasm StagingBreast NeoplasmsTegafurProspective StudiesLiverOvarian Neoplasms6-MercaptopurineVincristineAdenocarcinomaEndotoxinsGuanineHematocritChemotherapy, AdjuvantEhrlichia chaffeensisInjections, IntravenousRabbitsPlatinumRecurrenceEpothilones